Although increased ZFHX4 expression is documented in the HPA database (accessed on 10 May 2023) for several cancer types, it is higher in bone (including OS-derived cell lines) and rhabdoid cancers. The gene discussed is ZFHX4; the disease is rhabdoid tumor.